Chenguang Bio (IFC-40616)

Countries
  • China
Geographic location where the impacts of the investment may be experienced.
Specific Location
The company's headquater is based in Handan, Hebei province
Whenever identified, the area within countries where the impacts of the investment may be experienced. Exact locations of projects may not be identified fully or at all in project documents. Please review updated project documents and community-led assessments.
Financial Institutions
  • International Finance Corporation (IFC)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Proposed
Stage of the project cycle. Stages vary by development bank and can include: pending, approval, implementation, and closed or completed.
Bank Risk Rating
B
Environmental and social categorization assessed by the development bank as a measure of the planned project’s environmental and social impacts. A higher risk rating may require more due diligence to limit or avoid harm to people and the environment. For example, "A" or "B" are risk categories where "A" represents the highest amount of risk. Results will include projects that specifically recorded a rating, all other projects are marked ‘U’ for "Undisclosed."
Borrower
CHENGUANG BIOTECH GROUP CO LTD
A public entity (government or state-owned) provided with funds or financial support to manage and/or implement a project.
Sectors
  • Agriculture and Forestry
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Grant
The categories of the bank investment: loan, grant, guarantee, technical assistance, advisory services, equity and fund.
Investment Amount (USD)
$ 30.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Project Cost (USD)
$ 40.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Primary Source

Original disclosure @ IFC website

Updated in EWS Jan 10, 2020

Disclosed by Bank Jun 22, 2018

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
If provided by the financial institution, the Early Warning System Team writes a short summary describing the purported development objective of the project and project components. Review the complete project documentation for a detailed description.

The objective of the proposed investment of up to US$30 million for Chenguang Biotech Group Co., Ltd. (Chenguang” or the “Company”) is to support the company’s permanent working capital needs to increase production. Chenguang is a leading producer of natural, plant-based food extracts and additives in China.

The Company currently sources raw materials from Xinjiang Province, China and Andhra Pradesh, India, and is looking to expand its sourcing footprint to Africa, which is the subject of an IFC advisory engagement. Chenguang is headquartered in Hebei Province and is listed on the Shenzhen Stock Exchange with a market capitalization of US$700 million.

The Company uses plant-based inputs including paprika, capsicum, marigold to extract flavoring and coloring ingredients for the food industry as well as active substances for pharmaceutical use. Chenguang’s procurement of plant-based inputs provides an invaluable market access for farmers in its supply chain. The company has historically relied on short-term loans for its financing needs and is seeking a long-term loan from IFC to help strengthen its balance sheet and support growth in China as well as in India.

Early Warning System Project Analysis
For a project with severe or irreversible impacts to local community and natural resources, the Early Warning System Team may conduct a thorough analysis regarding its potential impacts to human and environmental rights.

 

 

Investment Description
Here you can find a list of individual development financial institutions that finance the project.

The total Project cost is around US$30-40 million and IFC investment is an up to US$30 million equivalent.

Private Actors Description
A Private Actor is a non-governmental body or entity that is the borrower or client of a development project, which can include corporations, private equity and banks. This describes the private actors and their roles in relation to the project, when private actor information is disclosed or has been further researched.

Mr. Lu Qingguo, Chairman, Founder and General Manager, is the largest shareholder of Chenguang with a shareholding of 18.58%. He is an executive council member of the China Food Additives and Ingredients Association. He has over 20 years of industry experience in the natural extracts space.

Chairman Lu Qingguo owns 18.58% of Chenguang and his wife, Ms. Li Yuezhai (board member of the Company) holds 4.17%. 13 senior management team members own 5.35%. The remaining shares are owned by public investors.

Private Actor 1 Private Actor 1 Role Private Actor 1 Sector Relation Private Actor 2 Private Actor 2 Role Private Actor 2 Sector
- - - - Chenguang Biotech Group Co Ltd Client -

Contact Information
This section aims to support the local communities and local CSO to get to know which stakeholders are involved in a project with their roles and responsibilities. If available, there may be a complaint office for the respective bank which operates independently to receive and determine violations in policy and practice. Independent Accountability Mechanisms receive and respond to complaints. Most Independent Accountability Mechanisms offer two functions for addressing complaints: dispute resolution and compliance review.

1/ The Project Contact

Company: Chenguang Biotech Group Co., Ltd. 
Point of Contact: Zhou Jing 
Title: Board Secretary 
Telephone Number: +86 310 8859024 
email: 18003309990@126.com 
Mailing Address: No.1 Chenguang Road, Quzhou County, Hebei Province, China 057250 
Website: ccc.cn-cg.com 

2/General IFC Inquiries
IFC Communications
2121 Pennsylvania Avenue, NW
Washington DC 20433
Telephone: 202-473-3800
Fax: 202-974-4384

3/The Project Information Access

No.1 Chenguang Road, Quzhou County, Hebei Province, China, 057250

ACCOUNTABILITY MECHANISM OF IFC

The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org. You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org/

How it works

How it works